The role of difluprednate ophthalmic emulsion in clinical practice
Karim N Jamal1,2, David G Callanan11Texas Retina Associates, Arlington, Texas, USA; 2Current affiliation: Retinal Consultants of Arizona, Phoenix, Arizona, USAAbstract: The mainstay in the treatment of ocular inflammation, either post-surgical or endogenous, is the use of steroids. While these agent...
Guardado en:
Autores principales: | Karim N Jamal, David G Callanan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fd236e7436c94fffad716c56ae4ccaab |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Dose uniformity of topical corticosteroid preparations: difluprednate ophthalmic emulsion 0.05% versus branded and generic prednisolone acetate ophthalmic suspension 1%
por: William Stringer, et al.
Publicado: (2010) -
Difluprednate ophthalmic emulsion 0.05% (Durezol®) administered two times daily for managing ocular inflammation and pain following cataract surgery
por: Stephen Smith, et al.
Publicado: (2010) -
Difluprednate for the prevention of ocular inflammation postsurgery: an update
por: Donnenfeld ED
Publicado: (2011) -
Topical difluprednate for the treatment of Harada’s disease
por: Onishi SM, et al.
Publicado: (2015) -
An evaluation of Retaine™ ophthalmic emulsion in the management of tear film stability and ocular surface staining in patients diagnosed with dry eye
por: Ousler III G, et al.
Publicado: (2015)